Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology
Jia Xin Yu(Tisch Hospital), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Mary E. Duffy(Tisch Hospital), Verónica Miguela(Tisch Hospital), Alexander P. Scopton(Tisch Hospital), Carlos Villacorta-Martín(Icahn School of Medicine at Mount Sinai), Marina Ruiz de Galarreta(Icahn School of Medicine at Mount Sinai), Augusto Villanueva(NYU Langone Health), Amanda J. Craig(National Institutes of Health), Ernesto Guccione(Tisch Hospital), Amaia Lujambio(Unknown), Alexander Rialdi(Tisch Hospital), Lisa Silber(Icahn School of Medicine at Mount Sinai), Andres Y. Maldonado(Icahn School of Medicine at Mount Sinai)
Cited by 21
Related Papers
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
|Gastroenterology|2008|726
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
|Annual Review of Biochemistry|2011|389